Search Results

There are 9808 results for: content related to: Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma

  1. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1581–1589, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12591

  2. MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 1077–1086, Valentina Vaira, Massimo Roncalli, Carlo Carnaghi, Alice Faversani, Marco Maggioni, Claudia Augello, Lorenza Rimassa, Tiziana Pressiani, Gaia Spagnuolo, Luca Di Tommaso, Stefano Fagiuoli, Elena Rota Caremoli, Massimo Barberis, Roberto Labianca, Armando Santoro and Silvano Bosari

    Version of Record online : 20 JUL 2014, DOI: 10.1111/liv.12636

  3. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 1036–1047, Annagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, Alberta Cappelli, Alessandro Granito, Alessandro Cucchetti, Sara Marinelli, Cinzia Pettinato, Virginia Erroi, Silvia Fiumana, Luigi Bolondi, Mauro Bernardi, Franco Trevisani and on behalf ofBLOG (Bologna Liver Oncology Group)

    Version of Record online : 20 MAY 2014, DOI: 10.1111/liv.12574

  4. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2147–2154, Yu Yang, Feng Wen, Jianliang Li, Pengfei Zhang, Wenhui Yan, Ping Hao, Feng Xia, Feng Bi and Qiu Li

    Version of Record online : 7 MAR 2015, DOI: 10.1111/liv.12805

  5. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma

    Liver International

    Volume 34, Issue 5, May 2014, Pages: 795–801, Ju-Yeon Cho, Yong-Han Paik, Hee Chul Park, Jeong Il Yu, Won Sohn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik and Byung Chul Yoo

    Version of Record online : 12 JAN 2014, DOI: 10.1111/liv.12445

  6. Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment

    Liver International

    Volume 35, Issue 8, August 2015, Pages: 2001–2008, Francesca V. Negri, Barbara Dal Bello, Camillo Porta, Nicoletta Campanini, Sandro Rossi, Carmine Tinelli, Guido Poggi, Gabriele Missale, Silvia Fanello, Stefania Salvagni, Andrea Ardizzoni and Silini Enrico Maria

    Version of Record online : 22 JAN 2015, DOI: 10.1111/liv.12778

  7. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 620–626, Jens Ricke, Karsten Bulla, Frank Kolligs, Markus Peck-Radosavljevic, Peter Reimer, Bruno Sangro, Eckart Schott, Kerstin Schütte, Chris Verslype, Jerzy Walecki, Peter Malfertheiner and for the SORAMIC study group

    Version of Record online : 8 JUL 2014, DOI: 10.1111/liv.12622

  8. Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat

    Liver International

    Volume 34, Issue 4, April 2014, Pages: 521–534, Ying-Ying Yang, Ren-Shyan Liu, Pei-Chang Lee, Yi-Chen Yeh, Yi-Tsau Huang, Wei-Ping Lee, Kuei-Chuan Lee, Yun-Cheng Hsieh, Fa-Yauh Lee, Tat-Wei Tan and Han-Chieh Lin

    Version of Record online : 2 SEP 2013, DOI: 10.1111/liv.12299

  9. Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma

    Liver International

    Volume 36, Issue 7, July 2016, Pages: 1033–1042, Francesca Romana Ponziani, Sherrie Bhoori, Alessandro Germini, Marco Bongini, Maria Flores, Carlo Sposito, Antonio Facciorusso, Antonio Gasbarrini and Vincenzo Mazzaferro

    Version of Record online : 20 JAN 2016, DOI: 10.1111/liv.13052

  10. Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study

    Liver International

    Volume 36, Issue 8, August 2016, Pages: 1196–1205, Masatoshi Kudo, Riccardo Lencioni, Jorge A. Marrero, Alan P. Venook, Jean-Pierre Bronowicki, Xiao-Ping Chen, Lucy Dagher, Junji Furuse, Jean-Francois H. Geschwind, Laura Ladrón de Guevara, Christos Papandreou, Arun J. Sanyal, Tadatoshi Takayama, Seung Kew Yoon, Keiko Nakajima, Robert Lehr, Stephanie Heldner and Sheng-Long Ye

    Version of Record online : 1 APR 2016, DOI: 10.1111/liv.13096

  11. Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis

    Liver International

    Charlotte E. Costentin, Thomas Decaens, Alexis Laurent, Jean-Charles Nault, Bernard Paule, Christian Letoublon, Alain Luciani, Julien Calderaro, René Adam, Ivan Bricault, Giuliana Amaddeo, Daniel Cherqui, Ariane Mallat, Didier Samuel, Christophe Duvoux, Nathalie Ganne-Carrié, Françoise Roudot-Thoraval and Eric Vibert

    Version of Record online : 13 JUL 2017, DOI: 10.1111/liv.13491

  12. Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)

    Liver International

    Volume 33, Issue 3, March 2013, Pages: 327–337, Joong-Won Park, Deepak Amarapurkar, Yee Chao, Pei-Jer Chen, Jean-Francois H. Geschwind, Khean Lee Goh, Kwang-Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun-Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T Poon, Chee-Kiat Tan, Tawesak Tanwandee, Gaojun Teng and Ann-Lii Cheng

    Version of Record online : 18 JAN 2013, DOI: 10.1111/liv.12083

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 33, Issue 5, 808, Version of Record online: 7 APR 2013

  13. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US

    Liver International

    Volume 33, Issue 4, April 2013, Pages: 605–615, Katsutoshi Sugimoto, Fuminori Moriyasu, Kazuhiro Saito, Nicolas Rognin, Naohisa Kamiyama, Yoshihiro Furuichi and Yasuharu Imai

    Version of Record online : 11 JAN 2013, DOI: 10.1111/liv.12098

  14. Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1nu mice

    Liver International

    Volume 32, Issue 4, April 2012, Pages: 574–581, Carmen Eicher, Alexander Dewerth, Bettina Kirchner, Steven W. Warmann, Joerg Fuchs and Sorin Armeanu-Ebinger

    Version of Record online : 18 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02729.x

  15. You have full text access to this OnlineOpen article
    Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2155–2166, Joong-Won Park, Minshan Chen, Massimo Colombo, Lewis R. Roberts, Myron Schwartz, Pei-Jer Chen, Masatoshi Kudo, Philip Johnson, Samuel Wagner, Lucinda S. Orsini and Morris Sherman

    Version of Record online : 25 MAR 2015, DOI: 10.1111/liv.12818

  16. Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?

    Liver International

    Volume 33, Issue 3, March 2013, Pages: 488–493, Giovanni Brandi, Francesco de Rosa, Laura Calzà, Stefania Di Girolamo, Manuel Tufoni, Carmen Serena Ricci, Fabio Cirignotta, Paolo Caraceni and Guido Biasco

    Version of Record online : 12 FEB 2013, DOI: 10.1111/liv.12102

  17. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo

    Liver International

    Volume 34, Issue 3, March 2014, Pages: 447–461, Annabelle Vogt, Elisabeth Sievers, Veronika Lukacs-Kornek, Georges Decker, Esther Raskopf, Nadja Meumann, Hildegard Büning, Tilman Sauerbruch, Christian P. Strassburg, Ingo G. H. Schmidt-Wolf and Maria A. Gonzalez-Carmona

    Version of Record online : 2 SEP 2013, DOI: 10.1111/liv.12284

  18. A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib

    Liver International

    Volume 36, Issue 8, August 2016, Pages: 1206–1212, Manuel A. de la Torre, Juan Buades-Mateu, Pedro A. de la Rosa, Alberto Lué, Francisco J. Bustamante, María T. Serrano, Milagros Testillano, Sara Lorente, Juan I. Arenas, Cristina Gil, Mercedes Iñarrairaegui and Bruno Sangro

    Version of Record online : 23 MAR 2016, DOI: 10.1111/liv.13098

  19. A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma

    Liver International

    Volume 36, Issue 12, December 2016, Pages: 1821–1828, Julien Edeline, Jean-Frédéric Blanc, Philip Johnson, Boris Campillo-Gimenez, Paul Ross, Yuk Ting Ma, Judy King, Richard A. Hubner, Kate Sumpter, Suzanne Darby, Jeff Evans, Chinenye Iwuji, Daniel Swinson, Peter Collins, Kinnari Patel, Iqtedar Muazzam, Daniel H. Palmer and Tim Meyer

    Version of Record online : 22 JUN 2016, DOI: 10.1111/liv.13170

  20. You have free access to this content
    Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 174–183, Ann Lii Cheng, Deepak Amarapurkar, Yee Chao, Pei-Jer Chen, Jean-François Geschwind, Khean L. Goh, Kwang-Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun-Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T. Poon, Chee-Kiat Tan, Tawesak Tanwandee, Gaojun Teng and Joong-Won Park

    Version of Record online : 20 NOV 2013, DOI: 10.1111/liv.12314